10 nominees · 5 ballot items.
Elect ten directors; ratify PwC as independent auditors; advisory approval of named executive officer compensation; approve 2026 Stock Incentive Plan; vote on stockholder proposal on shareholder approval for excessive golden parachutes.
Elect the ten director nominees named in the proxy statement to hold office until the 2027 Annual Meeting.
Ratify PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for 2026.
A non-binding advisory vote to approve the compensation disclosed for the Company’s Named Executive Officers.
Approve the Humana Inc. 2026 Stock Incentive Plan to authorize equity awards to employees, directors, and consultants (10.8M share reserve, various governance features).
The proposal asks shareholders to approve the Humana Inc. 2026 Stock Incentive Plan, which would replace the Prior Plan for future grants and reserve 10.8 million shares (counting rules apply, with 2.86-for-1 counting for full-value awards). Management seeks approval to ensure the company has sufficient equity to attract and retain talent and align pay with long-term performance. The plan includes governance features intended to limit shareholder dilution and protect stockholder interests: no evergreen increases, limits on liberal share recycling, no repricing without stockholder approval, no dividends on options or SARs, and annual limits on non-employee director compensation. The Board recommends the plan arguing it balances dilution concerns (estimated fully-diluted overhang 5.2% to 10.2% depending on award type) with the need to provide competitive equity compensation tied to performance. Approval requires majority of votes cast; brokers lack discretionary authority so broker non-votes will have no effect. The Board’s rationale emphasizes competitiveness, retention, and explicit protections (clawback, change-in-control treatment, and plan limits) that it believes align management and shareholder interests.
Require shareholder approval for any Named Executive Officer severance package exceeding 2.99x base salary plus target bonus; applies to severance and accelerated equity vesting.
The shareholder proposal, submitted by John Chevedden, asks the Board to require shareholder approval — via a non-binding vote — for any new or renewed Named Executive Officer severance/termination package estimated to exceed 2.99 times base salary plus target short-term bonus. The proponent argues this would provide a check on overly generous golden parachutes, citing Humana’s stock decline since 2020 and comparable support at other companies. The Board opposes the proposal, stating that existing severance and change-in-control policies provide appropriate limits and governance oversight and that the proposal would disadvantage Humana’s ability to attract and retain executives and is unnecessary given existing stockholder engagement and robust disclosure. The company highlights that its severance policy cash payouts are below the proposed 2.99x threshold, that equity acceleration largely requires death, disability or double-trigger termination post-change-in-control, and that the Compensation Committee — an independent board committee with an independent consultant — reviews separations on a case-by-case basis. The proposal would be precatory if passed. The corporate context includes detailed disclosure of current severance, CIC policies, and scenarios with estimated payouts in the proxy, showing the Board’s process for overseeing post-employment compensation and arguing the measure would reduce flexibility and harm competitiveness.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DODGE COX | 9.48% | 11,380,673 | $2.0B |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.53% | 7,838,762 | $1.4B |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.84% | 5,808,435 | $1.0B |
| 4 | STATE STREET CORP | 4.54% | 5,452,992 | $950M |
| 5 | PZENA INVESTMENT MANAGEMENT LLC | 4.48% | 5,378,289 | $933M |
| 6 | BlackRock, Inc. | 3.41% | 4,088,142 | $709M |
| 7 | Sessa Capital IM, L.P. | 3.10% | 3,727,740 | $646M |
| 8 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.64% | 3,165,046 | $549M |
| 9 | EAGLE CAPITAL MANAGEMENT LLC | 2.47% | 2,967,074 | $514M |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.45% | 2,939,029 | $509M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.